Authors:
Swann, E
Moody, CJ
Stratford, MRL
Patel, KB
Naylor, MA
Vojnovic, B
Wardman, P
Everett, SA
Citation: E. Swann et al., Rates of reductive elimination of substituted nitrophenols from the (indol-3-yl)methyl position of indolequinones, J CHEM S P2, (8), 2001, pp. 1340-1345
Authors:
Everett, SA
Naylor, MA
Barraja, P
Swann, E
Patel, KB
Stratford, MRL
Hudnott, AR
Vojnovic, B
Locke, RJ
Wardman, P
Moody, CJ
Citation: Sa. Everett et al., Controlling the rates of reductively-activated elimination from the (indol-3-yl)methyl position of indolequinones, J CHEM S P2, (5), 2001, pp. 843-860
Authors:
Swann, E
Barraja, P
Oberlander, AM
Gardipee, WT
Hudnott, AR
Beall, HD
Moody, CJ
Citation: E. Swann et al., Indolequinone antitumor agents: Correlation between quinone structure and rate of metabolism by recombinant human NAD(P)H : quinone oxidoreductase. Part 2, J MED CHEM, 44(20), 2001, pp. 3311-3319
Authors:
Winski, SL
Swann, E
Hargreaves, RHJ
Dehn, DL
Butler, J
Moody, CJ
Ross, D
Citation: Sl. Winski et al., Relationship between NAD(P)H : quinone oxidoreductase 1 (NQO1) levels in aseries of stably transfected cell lines and susceptibility to antitumor quinones, BIOCH PHARM, 61(12), 2001, pp. 1509-1516